Algernon Pharmaceuticals Inc C.AGN

Approval for Phase 2b/3

[CaboWabo5150]

https://www.streetwisereports.com/article/2020/07/14/potential-covid-19-treatment-is-ready-for-prime-time.html

[294ever]

If what streetwise report says is accurate as quoted from their July 14/2020 article below: The company anticipates it will take a few months to enroll all the patients. The treatment lasts two weeks, and another two weeks are needed for follow up, and then time for data collection, so within three to four months Algernon expects to have data about the drug's efficacy as a treatment for

[talisman47]

I don't think the article was correct in saying it would take 3-4 months to find 150 candidates for the 2b trials. That doesn't make sense. Algernon is fast tarcking all this as much as possible. I still think we may have some update possibly around end of July, early August.

[294ever]

Hi Talisman i appreciate your optimism, however realistically if data comes back in 3-4 months that's still fast. Being said the streetwise article is contrary to their very optimistic news releases.  June 25 news release excerpt:   Study Start Date  Enrollment of the 1st patient for the Phase 2b/3 study is expected before the end of July 2020. It is difficult to

[BehStreet]

294ever, I disagree. It will take a few months to enroll patients, but not all need to be enrolled to start a trail, ie: they are still enrolling after first patient dosed. This is a "continuous process". Below is the excerpt from the article, if we are taking this article "literally", then we should expect data in late Octorber / November 2020, 4th quarter of this year. Hmmm..

[294ever]

Hi Behstreet Thank you for your insight. Always look forward to your posts You make a good point here with it being a continuous trial. Probably what threw me is when Mr Moreau mentioned in his Facebook interview that not all the sites are prepared yet due to legal etc.Understandably these things can't just happen overnight, however I'm sure you can see my point that sometimes there